Purchase Order 36C26124P0007

Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, was awarded a firm fixed-price purchase order valued at $220,400 by Veterans Integrated Service Network 21 (VISN 21) of the Department of Veterans Affairs on October 1, 2023. The contract calls for the supply of Gallium-68 Dotatate (Netspot) radiopharmaceutical doses and associated materials to support nuclear medicine diagnostic imaging procedures at VA Palo Alto Health Care System. The award is non-set-aside and requires the vendor to deliver prepared doses within 30 minutes of scheduled calibration time while maintaining Nuclear Regulatory Commission licensing and regulatory compliance. The contract is scheduled to run through September 30, 2024, with pricing structured at $70 per dose and a $7 cancellation fee for cancellations made less than 24 hours before the scheduled delivery time.

Jubilant Radiopharma, a small disadvantaged business and subsidiary of Jubilant Life Sciences Limited, serves as a critical supplier of specialized radiopharmaceuticals to the VA nationwide. The company holds extensive Indefinite Delivery Vehicle contracts across multiple VA regional networks with ceiling values ranging from $220,000 to $39.8 million, positioning it as a key provider of nuclear medicine products essential for diagnostic imaging and cancer treatment support across the VA's healthcare system. This purchase order represents one of numerous delivery orders and task orders the company fulfills under its established contract vehicles with the Veterans Health Administration.